AMAT at $534: Huge Upside With a Huge Hurdle Approaching

Photo of Alex Sirois
By Alex Sirois Published

Quick Read

  • Gary Dickerson raised the 2026 semiconductor equipment growth outlook to "more than 30%," anchoring the bull case for a multi-quarter re-rating.

  • AMAT has beaten estimates 18 of the last 20 quarters, yet free cash flow collapsed 80% despite delivering a record $7.91B in revenue.

  • At $534, a China revenue reset below 20%, another free cash flow miss, or a walked-back full-year outlook each invalidates the Buy thesis.

  • The most widely read finance newsletter on Substack isn't published by a bank, it's Doomberg, where 383,000+ readers get the energy and macro analysis the mainstream press misses. 24/7 Wall St. readers save 17% on their first year here.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
AMAT at $534: Huge Upside With a Huge Hurdle Approaching

© appliedmaterials.com

At $534, Applied Materials (NASDAQ:AMAT | AMAT Price Prediction) is a Buy for investors willing to underwrite binary event risk into the August 13 earnings report. The stock has rebounded 22.41% from its late July low near $436, yet still sits well below its June high near $740.

Applied Materials is the largest U.S. maker of semiconductor fabrication equipment, selling the deposition, etch, and inspection tools that TSMC, Samsung, SK hynix, and Micron use to build leading-edge logic and memory. CEO Gary Dickerson has framed the current cycle around AI infrastructure, and last quarter he raised the calendar 2026 semi equipment growth outlook to “more than 30%” from a prior “over 20%.”

That upgrade, combined with a rally from roughly $177 a year ago, is why this earnings report carries so much weight.

Why AI Capex Still Argues for Higher Prices

The bull case starts with a widening AI capex funnel and Applied’s leverage to Gate-All-Around transistors at 2nm, high-bandwidth memory, and advanced packaging. Q2 FY2026 delivered record revenue of $7.91 billion, up 11.4% year over year, with net income up 31.3% and non-GAAP gross margin expanding to 50.0%.

Guidance for the August earnings report calls for roughly $8.95 billion in revenue and $3.36 in non-GAAP EPS, and the company has beaten estimates in 18 of the last 20 quarters. The consensus target sits at $629.09, and Polymarket traders currently price a 92.5% probability of another beat.

Why the Setup Could Still Break

The bear case is that a lot is already in the price. Shares trade at a 51 trailing P/E and a 32 forward P/E, both stretched for a cyclical equipment name. Free cash flow collapsed 80.21% year over year in Q2 to $210 million despite record revenue, a working capital red flag.

China accounted for 26% of Q2 revenue, and the company paid a settlement with the Commerce Department earlier this year over export controls. Historically, AMAT has fallen an average of 2.18% on earnings day even after beats, including a 14.07% post-earnings drop last October.

Why Some Investors Will Wait

The hold argument is timing. Fundamentals are strong, but the stock is down 9.88% over the past month even after the recent snapback, and the next report is a coin-flip on price reaction regardless of the headline number. Waiting for a clean read on China revenue, free cash flow recovery, and export-control posture is defensible.

What the Numbers Actually Say

Shares currently trade at $534.24. The 39-analyst consensus target of $629.09 implies meaningful upside. The breakdown skews bullish:

  • Strong Buy: 4
  • Buy: 28
  • Hold: 7
  • Sell: 0

AMAT is up 108.4% year to date and 200.44% over the past year, versus 12.89% and 22.58% for the S&P 500. TTM EPS sits at $10.62, and management raised the dividend 15% to $0.53 per share.

Why $534 Is Still a Buy

At $534, Applied Materials is a Buy. The path to price appreciation runs directly through the August 13 report and the calendar 2026 growth trajectory management already telegraphed. If Q3 lands near the guided $8.95 billion and DRAM mix keeps rising with HBM demand, the “more than 30%” equipment growth framing becomes the anchor for 2027 estimates.

The risk/reward at this entry hinges on accepting a possible sharp intraday drawdown for a multi-quarter re-rating. The invalidation is specific: a China revenue reset below 20%, another free cash flow air pocket, or a walked-back full-year outlook. Any of those would force a reassessment.

Investors who can stomach a double-digit event-day move own a category leader in the single most important capex cycle of the decade. Buying a compounder into a raised outlook, even at a stretched multiple, has historically paid off more often than waiting for a cleaner entry that rarely arrives.

Contact [email protected] for any questions or corrections.

Photo of Alex Sirois
About the Author Alex Sirois →

Alex Sirois is a financial writer with experience spanning both retail and institutional investing. He has written for InvestorPlace and held roles at BNY Mellon and Bernstein, giving him a perspective that bridges Main Street portfolios and Wall Street analysis.

Alex holds an MBA from George Washington University and has built his career across multiple industries, including e-commerce, education, and translation — a breadth of experience that informs how he breaks down complex financial topics for everyday investors. His writing is conversational, actionable, and grounded in long-term, buy-and-hold investing principles.

At 247 Wall St., Alex focuses on delivering analysis that is both accessible and useful, with a clear emphasis on helping readers make more informed decisions with their money.

Continue Reading

Top Gaining Stocks

CPRT Vol: 12,422,910
Fox
FOX Vol: 742,648
AMD
AMD Vol: 20,453,273
Fox
FOXA Vol: 5,225,537
NRG Vol: 822,053

Top Losing Stocks

CTRA Vol: 73,319,495
AVGO Vol: 21,588,326
AMAT Vol: 10,009,314
GDDY Vol: 1,235,477
ORCL Vol: 15,983,061